These findings indicate that the JAG1–NOTCH2 axis serves as a key mediator of proinflammatory crosstalk between epithelial cells and macrophages during periodontitis, highlighting the potential therapeutic implications of targeting this pathway to reduce inflammation and alveolar bone loss in patients with periodontal disease. Here, JAG1 is linked to periodontal disorder.